FIELD: organic chemistry, heterocyclic compounds, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of heteroarylalkylpiperazine of the general formula (I):
wherein m = 1, 2 or 3; q means NH or oxygen atom (O); R1, R2, R3, R4 and R5 are taken independently among the group including hydrogen atom, (C1-C15)-alkyl, OR20 wherein R20 represents hydrogen atom; R6, R7 and R8 represent hydrogen atom; R9, R10, R11, R12, R13, R14, R15 and R16 are taken independently among the group including hydrogen atom, (C1-C4)-alkyl; or R9 and R10 in common with carbon atom to which they are joined form carbonyl group; R17 means heteroaryl that is taken among the group including indolyl, benzoxazolyl, benzothiazolyl, quinolinyl, isoquinolinyl, pyridyl, benzopyrazinyl substituted optionally with 1-2 substitutes taken among the group including hydrogen atom, CF3 group, (C1-C8)-alkyl, phenyl, CON(R20)2. Compounds elicit property as a partial inhibitor of oxidation of fatty acids and can be used in therapy for protection of skeletal muscles against results of muscular or systemic diseases. Also, invention describes a pharmaceutical composition based on the claimed compounds.
EFFECT: valuable medicinal properties of compounds.
39 cl, 3 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USING AS INHIBITORS OF ALIPHATIC ACIDS OXIDATION | 2002 |
|
RU2300533C2 |
METHOD FOR TREATING DIABETES | 2003 |
|
RU2320343C2 |
NEW COMPOUNDS AS MODULATOR OF OPIOTIC RECEPTORS | 2003 |
|
RU2332411C2 |
METHODS AND COMPOSITIONS IMPROVING PATIENT'S TOLERANCE OF MYOCARDIAL VISUALISATION TECHNIQUE | 2007 |
|
RU2459626C2 |
HETEROAROMATIC DERIVATIVES OF UREA AND USE THEREOF AS GLUCOKINASE ACTIVATORS | 2005 |
|
RU2386622C2 |
CYCLIC AZAINDOLE-3-CARBOXAMIDE, PRODUCTION AND USE THEREOF AS THERAPEUTIC PREPARATIONS | 2009 |
|
RU2487874C2 |
CYCLOPAMINE ANALOGUES AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2403256C2 |
METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
3,4-DISUBSTITUTED CYCLOBUTENE-1,2-DIONES AS LIGANDS OF CXC-CHEMOKINE RECEPTOR | 2002 |
|
RU2344123C9 |
MDM2 AND P53 INTERACTION INHIBITORS | 2008 |
|
RU2477724C2 |
Authors
Dates
2005-01-10—Published
2001-10-19—Filed